Desmoid Tumors: A Review of the Literature and Pharmacologic Management
Authors:
- Eellan SivanesanESEellan Sivanesan
- Melvin C. GitlinMGMelvin C. Gitlin
- 2 April 2016
- journal article
- review article
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 30 (2) , 99-105
Abstract
Desmoid tumors represent a nonmalignant proliferation of fibroblast-related cells. These rare tumors are difficult to treat and often persist as indolent, lifelong conditions. There are a number of treatments available for both anatomic and symptom regression. Some of these treatments, unfortunately, may not provide long-lasting results and may result in further complications. Pain is a distressing symptom that may be due to the tumor itself or the result of utilized treatments. Pharmacologic therapies represent a noninvasive alternative to surgical resection. Pain symptoms require therapeutic regimens that must be modified as the tumor evolves in expression. The individualized pain treatment program utilized may often reflect principles used in both nonmalignant and malignant pain management models. This review seeks to increase awareness of desmoid tumors through a review of the literature and discussion of its pharmacotherapeutic management.Keywords
This publication has 55 references indexed in Scilit:
- The treatment of desmoid tumors: a stepwise clinical approachAnnals of Oncology, 2012
- A Review of Potential Adverse Effects of Long-Term Opioid TherapyThe Primary Care Companion For CNS Disorders, 2012
- Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid TumorsCancer Research, 2012
- A to Z of Desmoid TumorsAmerican Journal of Roentgenology, 2011
- Update on desmoid tumorsAnnals of Oncology, 2011
- Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)Annals of Oncology, 2011
- High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease managementBritish Journal of Cancer, 2010
- A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 casesEuropean Journal of Surgical Oncology, 2009
- Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid TumorsThe American Journal of Pathology, 2008
- Ca2+ channel α2δ ligands: novel modulators of neurotransmissionTrends in Pharmacological Sciences, 2007